Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (1235)	12/15/1998 3:40:00 PM
From: John L.	Read Replies (2) \| Respond to of 1432

If the FDA questions were so routine why is there such a delay in getting a response to them? I thought Barkin said they would have a reply before Thanksgiving so the FDA has had 2 weeks to review there response. I thought this would happen quickly so the FDA could claim they have improved there response time for regular NDA submittals. It is quite disapointing that Abbott will probably not sell any Hextend in 1998. I hope 1999 doesn't drag out like '98 has for BTIM.